82 related articles for article (PubMed ID: 21051252)
1. Insulin-glucose infusion given before hemodialysis increases IGF-I in type 2 diabetes patients with chronic kidney disease.
Lindgren BF; Jacobson SH; Brismar K
Growth Horm IGF Res; 2010 Dec; 20(6):422-6. PubMed ID: 21051252
[TBL] [Abstract][Full Text] [Related]
2. Decreased bioavailability of insulin-like growth factor-I, a cause of catabolism in hemodialysis patients?
Lindgren BF; Odar-Cederlöf I; Ericsson F; Brismar K
Growth Regul; 1996 Sep; 6(3):137-43. PubMed ID: 8894646
[TBL] [Abstract][Full Text] [Related]
3. Marked reductions in bioactive insulin-like growth factor I (IGF-I) during hemodialysis.
Ivarsen P; Chen JW; Tietze I; Christiansen JS; Flyvbjerg A; Frystyk J
Growth Horm IGF Res; 2010 Apr; 20(2):156-61. PubMed ID: 20044291
[TBL] [Abstract][Full Text] [Related]
4. Serum and urinary levels of insulin-like growth factor I in patients with chronic renal disease and diabetes mellitus: its clinical implication.
Fujihara M; Uemasu J; Kawasaki H
Clin Nephrol; 1996 Jun; 45(6):372-8. PubMed ID: 8793228
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
Iglesias P; Díez JJ; Fernández-Reyes MJ; Méndez J; Bajo MA; Aguilera A; Selgas R
Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339
[TBL] [Abstract][Full Text] [Related]
6. Blood levels of chromium in diabetic and nondiabetic hemodialysis patients.
Romero RA; Salgado O; Rodríguez-Iturbe B; Tahán JE
Transplant Proc; 1996 Dec; 28(6):3382-4. PubMed ID: 8962320
[No Abstract] [Full Text] [Related]
7. Association of serum levels of IGF-I and IGFBP-1 with renal function in patients with type 2 diabetes mellitus.
Akturk M; Arslan M; Altinova A; Ozdemir A; Ersoy R; Yetkin I; Ayvali E; Gonen S; Toruner F
Growth Horm IGF Res; 2007 Jun; 17(3):186-93. PubMed ID: 17329141
[TBL] [Abstract][Full Text] [Related]
8. Type 2 diabetes in patients with end-stage renal disease is not associated with further increased serum inflammatory parameters.
Bodlaj G; Berg J; Pichler R; Sailer T; Biesenbach G
J Nephrol; 2004; 17(1):112-7. PubMed ID: 15151267
[TBL] [Abstract][Full Text] [Related]
9. Comparison of aminophylline and insulin-dextrose infusions in acute therapy of hyperkalemia in end-stage renal disease patients.
Mahajan SK; Mangla M; Kishore K
J Assoc Physicians India; 2001 Nov; 49():1082-5. PubMed ID: 11868861
[TBL] [Abstract][Full Text] [Related]
10. [Intermittent peritoneal chronic dialysis in diabetic patients: effect of the technique on blood glucose and protein loss during the procedure].
García Ortiz R; Gómez M; Olea C
Rev Med Chil; 1989 Dec; 117(12):1367-73. PubMed ID: 2519375
[TBL] [Abstract][Full Text] [Related]
11. Rh/IGF-I/rhIGFBP-3 administration to patients with type 2 diabetes mellitus reduces insulin requirements while also lowering fasting glucose.
Clemmons DR; Moses AC; Sommer A; Jacobson W; Rogol AD; Sleevi MR; Allan G
Growth Horm IGF Res; 2005 Aug; 15(4):265-74. PubMed ID: 16005252
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor-I (IGF-I), insulin-like growth factor binding proteins (IGFBP) and insulin-like growth factor type I receptor in children with various status of chronic renal failure.
Houang M; Cabrol S; Perin L; Ducos B; Bensman A; Le Bouc Y
Growth Horm IGF Res; 2000 Dec; 10(6):332-41. PubMed ID: 11161964
[TBL] [Abstract][Full Text] [Related]
13. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A; Naderi AS
Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
[TBL] [Abstract][Full Text] [Related]
14. Insulin resistance is associated with increased serum concentration of IGF-binding protein-related protein 1 (IGFBP-rP1/MAC25).
López-Bermejo A; Khosravi J; Fernández-Real JM; Hwa V; Pratt KL; Casamitjana R; Garcia-Gil MM; Rosenfeld RG; Ricart W
Diabetes; 2006 Aug; 55(8):2333-9. PubMed ID: 16873698
[TBL] [Abstract][Full Text] [Related]
15. Microvascular permeability is increased in both types of diabetes and correlates differentially with serum levels of insulin-like growth factor I (IGF-I) and vascular endothelial growth factor (VEGF).
Brausewetter F; Jehle PM; Jung MF; Boehm BO; Brueckel J; Hombach V; Osterhues HH
Horm Metab Res; 2001 Dec; 33(12):713-20. PubMed ID: 11753756
[TBL] [Abstract][Full Text] [Related]
16. Improvement in nutritional parameters after initiation of chronic hemodialysis.
Pupim LB; Kent P; Caglar K; Shyr Y; Hakim RM; Ikizler TA
Am J Kidney Dis; 2002 Jul; 40(1):143-51. PubMed ID: 12087572
[TBL] [Abstract][Full Text] [Related]
17. IGF-1, IGFBP-3 and ALS in adult patients with chronic kidney disease.
Lepenies J; Wu Z; Stewart PM; Strasburger CJ; Quinkler M
Growth Horm IGF Res; 2010 Apr; 20(2):93-100. PubMed ID: 19932629
[TBL] [Abstract][Full Text] [Related]
18. Plasma levels of active and total ghrelin in renal failure: a relationship with GH/IGF-I axis.
Jarkovská Z; Hodková M; Sazamová M; Rosická M; Dusilová-Sulková S; Marek J; Justová V; Lacinová Z; Haluzík M; Haas T; Krsek M
Growth Horm IGF Res; 2005 Dec; 15(6):369-76. PubMed ID: 16198134
[TBL] [Abstract][Full Text] [Related]
19. Hemodialysis-related problems in patients with diabetes mellitus.
Kaississieh SD; Yen MC; Lazarus M; Lowrie EG; Goldstein HH; Takacs FJ; Hampers CL; Merrill JD
Kidney Int Suppl; 1974 Oct; (1):100-7. PubMed ID: 4533904
[No Abstract] [Full Text] [Related]
20. Effects of recombinant human growth hormone on muscle protein turnover in malnourished hemodialysis patients.
Garibotto G; Barreca A; Russo R; Sofia A; Araghi P; Cesarone A; Malaspina M; Fiorini F; Minuto F; Tizianello A
J Clin Invest; 1997 Jan; 99(1):97-105. PubMed ID: 9011582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
